Waleed H. Hassanein, President & CEO at TransMedics Group, Inc. (TMDX), sold 17,250 shares at $151.10 ($2.6M) on 2024-09-16, disclosed to the SEC on 2024-09-17.
Scheduled sale ($2.6M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.10 | 908 | $137K | 5.2% |
| 2 | $151.10 | 908 | $137K | 5.2% |
| 3 | $152.30 | 1,865 | $284K | 10.7% |
| 4 | $152.30 | 1,865 | $284K | 10.7% |
| 5 | $153.32 | 3,155 | $484K | 18.3% |
| 6 | $153.32 | 3,155 |
| $484K |
| 18.3% |
| 7 | $154.16 | 1,383 | $213K | 8.1% |
| 8 | $154.16 | 1,383 | $213K | 8.1% |
| 9 | $155.65 | 688 | $107K | 4.0% |
| 10 | $155.65 | 688 | $107K | 4.0% |
| 11 | $156.48 | 626 | $98K | 3.7% |
| 12 | $156.48 | 626 | $98K | 3.7% |
| Total | $153.42 avg | 17,250 | $2.6M | 100% |
| Filing → |
| TMDX | SELL | 2024-10-17 | $2.1M | — | Filing → |
| TMDX | SELL | 2024-08-23 | $7.8M | — | Filing → |
| TMDX | SELL | 2024-08-19 | $2.6M | — | Filing → |